Dr Brian S Niles, MD in Blytheville, AR - Urology

Dr Brian S Niles, MD is a Urology physician based in Blytheville, Arkansas. Dr Brian S Niles is licensed to practice in Arkansas (license number E-7820) and his current practice location is 609 Fulton St, Blytheville, Arkansas. He can be reached at his office (for appointments etc.) via phone at (870) 763-0855.

NPI number for Dr Brian S Niles is 1538498472 and his current mailing address is 609 Fulton St, Blytheville, Arkansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1538498472.

Contact Information

	Dr Brian S Niles, MD
	609 Fulton St, Blytheville, AR 72315-1922
	(870) 763-0855
	(870) 763-0858

Physician's Profile

Full Name	Dr Brian S Niles
Gender	Male
Speciality	Urology
Location	609 Fulton St, Blytheville, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1538498472
Provider Enumeration Date: 12/23/2009
Last Update Date: 10/31/2013

Medical Identifiers

Medical identifiers for Dr Brian S Niles such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538498472	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	2009034738 (Missouri)	Secondary
208800000X	Urology	E-7820 (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Brian S Niles is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Brian S Niles, MD 609 Fulton St, Blytheville, AR 72315-1922 Ph: (870) 763-0855	Dr Brian S Niles, MD 609 Fulton St, Blytheville, AR 72315-1922 Ph: (870) 763-0855

News Archive

Update on Nymox Pharmaceutical's Phase 3 program for NX-1207

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia. The most recent Safety Monitoring Committee meeting of April 30, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated no significant safety concerns for the trials to date.

Researchers find new U.S. trend in antibiotic resistance

A research team from The University of Texas Health Science Center at San Antonio, examining bacterial isolates obtained in hospital and non-hospital clinical settings between 2000 and 2006, has identified drug-resistant strains of E. coli and Klebsiella bacteria in more than 50 blood, urine and respiratory samples.

Findings may lead researchers to create urine-producing kidney through regenerative medicine

Various research groups are collecting different types of cells and turning them into induced pluripotent stem (iPS) cells that can then generate diverse types of cells and tissues in the body. Now investigators have transplanted kidney tissue made from human iPS cells into a mouse kidney, and they found that the animal's blood vessels readily connect to the human tissue.

Africa's economic expansion not strong enough to reach poverty MDG, U.N. report says

"Africa's economy expanded by 4.7 percent in 2010 and is expected to maintain similar growth over the next two years," according to the U.N.'s World Economic Situation and Prospects 2011 report, which was released Tuesday in the Ethiopian capital Addis Ababa, Deutsche Presse-Agentur/M&C reports.

Dr Brian S Niles, MD - Urology in Blytheville, AR